Fundz

Catheter Precision

South Carolina, United States · Biotechnology, Health Care, Manufacturing · 26 employees

Catheter Precision, Inc. is a U.S.-based innovative medical device company focused on electrophysiology products, bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is committed to developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.

Funding history

  • Series private placement — $1.0M — Jun 2026
  • Funding Round — $36.5M — Feb 2026
  • Funding Round — $1.5M — May 2025
  • Funding Round — $8.0M — Apr 2023
  • Funding Round — $7.6M — Oct 2022

Recent signals

  • Jun 07, 2026: SEC 8-K (1.01): On June 7, 2026, Catheter Precision, Inc. entered into a Securities Purchase Agreement with Volato Group, Inc. and other investors. Under this agreement, Catheter Precision agreed to purchase 2,941,176 shares of Volato's common stock at a price of $0.34 per share, totaling an aggregate purchase price of $1,000,000. The Private Placement is significant as it involves a notable investment in Volato, although there is no assurance that Catheter Precision will realize the current market value of the securities in future sales. The closing date of the transaction is expected to occur soon after, reflecting active capital engagement in the market.
  • Jun 07, 2026: Raised $1.0M in Series private placement
  • Apr 16, 2026: Acquired Catheter Precision acquires Flyte for aviation expansion
  • Apr 15, 2026: SEC 8-K (5.07): On April 15, 2026, Catheter Precision, Inc. held a Special Meeting of stockholders where approximately 49.5% of the outstanding shares were represented. The stockholders voted on six proposals, including the approval of the issuance of shares of common stock under a specific plan. The meeting was attended either in person or by proxy by 1,165,698 shares out of the 2,357,127 outstanding shares as of March 9, 2026. A detailed description of the proposals can be found in the definitive proxy statement filed with the SEC on March 23, 2026.
  • Mar 10, 2026: Acquired Catheter Precision acquires Fly Flyte for $11.55M
  • Feb 12, 2026: Raised $36.5M
  • Oct 10, 2025: SEC 8-K (5.02): On October 10, 2025, Catheter Precision, Inc. held a Special Meeting of stockholders to vote on three proposals, including an amendment to the Amended and Restated Certificate of Incorporation. Out of 1,487,266 shares of common stock outstanding as of the record date, September 10, 2025, 641,616 shares were represented at the meeting, accounting for approximately 43.1% of the shares entitled to vote. This vote reflects important decisions that could affect the company’s governance structure and future business operations, as it involved changes to fundamental corporate documents. Details of the proposals and the outcomes were provided in the definitive proxy statement filed with the SEC on September 15, 2025.
  • May 12, 2025: Raised $1.5M

See plans & pricing → Track Catheter Precision’s funding, hiring, and signals — with verified contacts — on Fundz.